Sweden-based Phase Holographic Imaging (PHI) has signed a collaboration agreement with Northeastern University of Boston, US, to provide HoloMonitor technology.
The HoloMonitor technology can be used in cell analysis applications and techniques based on non-invasive time-lapse imaging cytometry technology.
Both parties are also planning to establish a regional center of excellence to offer training for scientists using time-lapse cytometry techniques and to nurture cross-disciplinary collaborations in cell-based research.
Northeastern University pharmaceutical sciences department chair professor Mansoor Amiji said the university has partnered with PHI to expand the services offered by the department’s Core Imaging and Cytometry facility.
"The agreement with PHI represents the next step in establishing collaborative links with the life sciences industry and positioning Northeastern as a comprehensive imaging cytometry and technology center in line with other Centers of Research Excellence affiliated with the Department," Amiji added.
Northeastern University Core Imaging and Cytometry facility manager Ed Luther said: "PHI’s technology brings us the capability to visualize and quantify cells without stains that can interfere with cellular physiology."
PHI, which provides holographic time-lapse cytometry instrumentation and software, has customer base and scientific collaborations in cancer research, inflammatory and autoimmune diseases, stem cell biology, gene therapy, regenerative medicine and toxicological studies.
Image: An unstained cell imaged by the HoloMonitor M4. Photo: courtesy of PRNewswire/ Phase Holographic Imaging.